U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07893158) titled 'A Study of Nicotine Orodispersible Tablet on Craving Relief of Male and Female Smoker Volunteers' on Oct. 02.
Brief Summary: The objective of the study is to evaluate the relief of momentary urge to smoke at pre-specified early post-dose time points after administration of Nic ODT compared to Placebo ODT.
Study Start Date: Oct. 05
Study Type: INTERVENTIONAL
Condition:
Smoking Cessation
Nicotine Replacements Therapy
Intervention:
DRUG: Nicotine Mint Oro Dispersible Tablet (Nic ODT)
Nic ODT 2.0 mg, orally
DRUG: Placebo Oro Dispersible Tablet (Placebo ODT)
Placebo ODT, orally
Recruitment Status: RECRUITING
Sponsor: McNeil AB...